ClinicalTrials.Veeva

Menu
L

Leavitt Clinical Research | Idaho Falls, ID

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BAY3427080
Elinzanetant
TAK-279
IW-3300

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 12 total trials

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

The aim of this study is to assess whether IW-3300 is safe and works for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS). The m...

Enrolling
Interstitial Cystitis
Bladder Pain Syndrome
Drug: Placebo
Drug: IW-3300 rectal foam
Locations recently updated

The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque p...

Enrolling
Plaque Psoriasis
Drug: Placebo
Drug: Apremilast

A 4 month growth monitoring study of healthy term infants fed iron fortified infant formula. Infants will be fed ad-libitum for 16 weeks and growth w...

Enrolling
Infant Development
Other: Infant Formula

The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months...

Active, not recruiting
Growth
Other: Control Toddler Drink
Other: Control Infant Formula

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Other: Placebo
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

Trial sponsors

Abbott logo
Aussie Bubs logo
Bayer logo
Ironwood Pharmaceuticals logo
Novavax logo
Organon logo
P
Sanofi logo
Takeda logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems